Author

Andrew S. Ishizuka

National Institutes of HealthORCID 0000-0002-3024-7536Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Andrei Ramirez-Valdez· 2 shared Christopher M. GarlissiD· 2 shared Geoffrey M. LynniD· 2 shared Robert A. SederiD· 2 shared Ababacar DioufiD· 1 shared Alec Schrager· 1 shared Amelia M. LiasiD· 1 shared Amy R. NoeiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Andrei Ramirez-Valdez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyThe Journal of ImmunologyPeer-reviewedAug 29, 2026

Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres

Andrew S. Ishizuka, Christopher M. Garliss, Robert N. Goddu…·David R. Wilson

This study introduces oxidation-resistant (OXR) antigens by substituting cysteine and methionine with isosteres to improve peptide vaccine manufacturability without compromising immunogenicity.

DOI 10.1093/jimmun/vkag232

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 14, 2026

Spatiotemporal dynamics of adoptively transferred stem-like CD8+ T cells in the tumor microenvironment following vaccination

Dalton Hermans, Sloane Christian Fussell, Andrei Ramirez-Valdez…·Robert A. Seder

This study shows that stem-like CD8+ T cells, when used in adoptive cell therapy followed by vaccination, improve tumor control by altering the tumor microenvironment's transcriptomic profile.

DOI 10.64898/2026.05.12.724323

mousespatial transcriptomics

𝕏 PostBluesky

ImmunologyCell Reports MedicinePeer-reviewedJul 1, 2024

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

Lloyd D. W. King, David Pulido, Jordan R. Barrett…·Simon J. Draper

This paper develops a stabilized RH5 VLP vaccine that induces improved anti-malarial antibodies compared to a soluble protein vaccine in preclinical studies.

31 citationstop 1%

humanrat

𝕏 PostBluesky